|
|
|
|
EUROs for $1 DOLLAR: 3 MONTHS |
 | |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings
11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "BUY"for ALCON INC (NYSE:ACL) Stock.
ACL stock opening price was $145.07 per share.
Current price of NYSE:ACL Stock is $146.63 per share
and it is
$+1.02, (+0.70%) today
and it was trading in the daily range of $144.67 - 146.93 per share.
Current Bid Price for (NYSE:ACL) stock is $137.77 and the Ask Price is $155.07. In the last 52 weeks
ACL stock was trading in the range of $66.64 - 148.85. 50-Day Moving Average for (NYSE:ACL) stock is
$143.309 and 200-Day Moving Average is $124.782. On average analysts predict that One Year Target Estimated price for
(NYSE:ACL) stock is $158.55.
ALCON INC (NYSE:ACL) Market capitalization is $43.840B. (NYSE:ACL) stock average daily volume is
479,270 shares per day.
However, on last trading session of Nov 13, 2009
ACL stock traded 392,811 shares.
Also The Short Ratio for (NYSE:ACL) stock is 0.90.
On previous trading session ACL Stock closed at $145.61 per share.
Last year ALCON INC (NYSE:ACL) before taxes (EBITDA) (ttm) earned $2.507B on total revenue of $6.282B.
Earnings Per Share - EPS (ttm) for ACL stock is 6.558.
Also, (NYSE:ACL) Stock Price Per Earnings ratio - P/E is 22.20.
Thus, (NYSE:ACL) Stock Price/Sales (ttm) ratio is 6.93 and Price/Book (mrq) ratio is 8.06.
(NYSE:ACL) Stock pays a dividend of $3.49 per share which is a yield of 2.40%.
So at this time (NYSE:ACL) Stock maintains Trailing Annual Dividend Rate at 3.49
.
StockRing Recommendations for ALCON INC (NYSE:ACL) Stock are updated daily here
http://www.StockRing.com/sr/StockDetail.asp?StockName=ACL
If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com.
|
ACL Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
 | |
| 1 Year Dow Jones Chart |
1 Year S&P 500 Chart |
 |
 |
| 1 Year Nasdaq Chart |
1 Year Canada Chart |
 |
 |
|
| |
| 5 Days Dow Jones Chart |
5 Days S&P 500 Chart |
 |
 |
| 5 Days Nasdaq Chart |
5 Days Canada Chart |
 |
 |
|
ACL Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
|
| Last Trade: |
146.63 |
| Trade Time: |
Nov 13 |
| Change: |
+1.02, (+0.70%) |
| Prev Close: |
145.61 |
| Open: |
145.07 |
| Bid: |
137.77 |
| Ask: |
155.07 |
| 1y Target Est: |
$158.55 |
| 50-Day Moving Average: |
143.309 |
200-Day Moving Average:
|
124.782 |
| Short Ratio: |
0.90 |
| Trailing Annual Dividend Rate: |
3.49
|
|
| Day's Range: |
144.67 - 146.93 |
| 52wk Range: |
66.64 - 148.85 |
| Volume: |
392,811 |
| Avg Vol: |
479,270 |
| Market Cap: |
43.840B |
| P/E (ttm): |
22.20 |
| EPS (ttm): |
6.558 |
| Div & Yield: |
3.49 (2.40%) |
| Revenue (ttm): |
6.282B |
| Earnings before Tax (EBITDA) (ttm): |
2.507B |
| Price/Sales (ttm): |
6.93 |
| Price/Book (mrq): |
8.06 |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
|
|
|
|
EUROs for $1 DOLLAR: 3 MONTHS | |
| |
|
ALCON INC (NYSE: ACL) Company Information
Alcon Inc.
Bosch 69
PO Box 62
Hunenberg, 6331
Switzerland - Map
Phone: 41 41 785 88 88
Fax: 41 41 785 88 87
Web Site: http://www.alconinc.com
ALCON INC (NYSE: ACL) DETAILS
ALCON INC (NYSE: ACL) Index Membership: N/A
ALCON INC (NYSE: ACL) Sector: Healthcare
ALCON INC (NYSE: ACL) Industry: Medical Instruments & Supplies
ALCON INC (NYSE: ACL) Full Time Employees: 15,400
ALCON INC (NYSE: ACL) BUSINESS SUMMARY
Alcon, Inc. engages in the development, manufacture, and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products to treat primarily diseases and disorders of the eye in the United States and internationally. The company offers various prescription ophthalmic pharmaceutical products for glaucoma treatments; anti-infectives, anti-inflammatories, and combination therapies to treat bacterial, viral, and fungal infections of the eye and to control ocular inflammation; products to treat ocular allergies; combination anti-infective/anti-inflammatory products for ear infections; and generic ophthalmic and otic pharmaceutical products. Its ophthalmic surgical products consist of surgical equipment, single-use, and disposable products for cataract surgery; vitreoretinal surgical products; surgical procedure packs; and refractive products. The company?s consumer eye care products include contact lens care products, such as disinfecting solutions, cleaners, and lens rewetting drops; vision care products, including artificial tears to treat dry eye syndrome and ocular vitamins, as well as dietary supplements, such as Age Related Eye Disease Study Formula, Lutein, and Zeaxanthin formula. Alcon sells its pharmaceutical products to physicians, distributors, wholesalers, hospitals, government agencies, and large retailers; surgical products directly to hospitals and ambulatory surgical centers, and through distributors; and consumer eye care products directly to retailers and optical chains, as well as to distributors for resale directly to smaller retailers and eye care professionals. It has collaboration with River Plate Biotechnology, Inc. and AstraZeneca plc; and research and licensing agreement with PhiloGene Inc. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon, Inc. in December 2001. The company was founded in 1945 and is based in Hunenberg, Switzerland. Alcon, Inc. is a subsidiary of Nestle S.A.
ALCON INC (NYSE: ACL) KEY EXECUTIVES, SALARIES and BONUSES
Mr. Kevin J. Buehler , Age: 51
Chief Exec. Officer, Pres Salary: $ 960.00K Bonus: $ 2.35M
Mr. Richard J. Croarkin , Age: 54
Chief Financial Officer, Sr. VP of Fin. and Corp. Strategy Officer Salary: $ 720.00K Bonus: $ 0
Mrs. Elaine E. Whitbeck , Age: 54
Sr. VP, Corp. Sec. and Gen. Counsel Salary: $ 792.00K Bonus: $ 0
Dr. Sabri Markabi M.D., Age: 50
Chief Medical Officer and Sr. VP of R&D Salary: $ 380.00K Bonus: $ 0
Mr. Ed McGough , Age: 48
Sr. VP of Global Manufacturing and Technical Operations Salary: $ 570.00K Bonus: $ 0
|
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Options Intelligence Report : Options Activity Analysis For ACL, VIX, FEED, ODP, NRG, NVTL, LVS & MSTR
istockAnalyst.com - Oct 30, 2009
Alcon, Inc. (ACL) – Medical supplies producer, Alcon, attracted long-term bullish option traders to the May 2010 contract. Shares slipped slightly lower by 0.5% to $144.02 by noontime (EDT). It ...
Alcon Inc. Beats Analyst Expectations; ACL, MR, BCR
Learning Markets - Oct 28, 2009
Analysts were expecting Alcon Inc. (ACL) [Chart - News - Analysis] to report earnings of $1.45 for last quarter, but ACL beat expectations with actual earnings of $1.71---26 cents above the ...
Alcon Guides Higher
Trading Markets - Oct 27, 2009
Oct 27, 2009 (EarningsWhispers Guidance Summaries via Comtex) -- ACL -- Alcon Inc. (NYSE: ACL) said it now expects 2009 earnings of $6.60 to $6.70 per share. The company's previous guidance was ...
|
|
Fantasy Football: Stock WatchComcast SportsNet PhiladelphiaKevin Walter, WR, Texans: With Owen Daniels out for the year (torn ACL), Matt Schaub is going to have to find a different guy to throw to when Andre Johnson ...and more » |
|
|
No comments:
Post a Comment